CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 40 enrolled
Drug / intervention
Symbiotic +1 moredietary
Likely dose
Symbiotic product administered twice daily for seven days post-surgeryAI-extracted
Key inclusion· 2
  • ✓Head and neck cancer with primary surgical treatment
  • ✓Requires enteral nutrition by enteral tube
Key exclusion· 4
  • ✕Antibiotic use within three months before surgery
  • ✕Recent radiotherapy prior to enrollment
  • ✕Recent chemotherapy prior to enrollment
  • ✕Inflammatory bowel disease

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02654652
NCT02654652N/ACompleted
CompareCT.gov

Intestinal Function of Patients With Uper Air and Digestive Neoplasia Submitted to Surgical Treatment: Symbiotic Use Impact

Federal University of Minas Gerais·interventional·Posted Jan 13, 2016·Updated Jun 5, 2019

In Brief

A clinical study evaluating Symbiotic and Maltodextrin for Head and Neck Cancer and 2 related conditions. Completed, enrolled 40 participants across 1 site.

Detailed Summary

The purpose of this study is to determine whether the symbiotic use in patients with head and neck cancer impact on intestinal function after surgical treatment.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHead and Neck Cancer, Synbiotics, Nutrition Therapy
CountriesBrazil
Collaborators--

Timeline

N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedJan 13, 2016
Enrollment StartOct 1, 2014
Primary CompletionJan 1, 2016
Study CompletionJul 1, 2016
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 10.5 years ago

Interventions

Symbioticdietary

Intervention will consist of the adminitration of symbiotic product twice a day during seven days after surgical treatment

Maltodextrindietary

Intervention will consist of the adminitration of placebo product twice a day during seven days after surgical treatment